Thomas Jefferson University City Center and Abington — Philadelphia, Pennsylvania

Thomas Jefferson University City Center and Abington is a clinical research site located in Philadelphia, Pennsylvania, United States 19107.

Crixeo Health Trust Score: 46/100 (POOR). This profile has not yet been claimed by the site owner.

Thomas Jefferson University City Center and Abington has participated in 1 clinical trials.

Therapeutic areas: Squamous Cell Carcinoma of Head and Neck, Locally Advanced Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma.

Sponsors: Replimune Inc..

Sponsor Feasibility Report

Trust Score: 46/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Thomas Jefferson University City Center and Abington?

Thomas Jefferson University City Center and Abington has a Crixeo Trust Score of 46/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Thomas Jefferson University City Center and Abington conducted?

Thomas Jefferson University City Center and Abington has 1 clinical trials on record. Their work covers Squamous Cell Carcinoma of Head and Neck, Locally Advanced Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma.

Is Thomas Jefferson University City Center and Abington accredited by Crixeo Health?

Thomas Jefferson University City Center and Abington has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Thomas Jefferson University City Center and Abington?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.